Related Articles
Shana Randhava's Departure Marks a New Chapter for Estée Lauder’s Innovation Ventures
Shana Randhava is departing her role as Senior Vice President of New Incubation Ventures (NIV) at The Estée Lauder Companies, concluding a decade-long career with the beauty giant. Since 2021, Randhava led NIV, overseeing strategic acquisitions and investments in brands like Kilian Paris, Haeckels, Kiki World, Melt Season, Code Mint, and Vyrao. Her leadership extended to global initiatives such as Beauty & You in India and The Catalysts, fostering entrepreneurial support and market innovation. Randhava’s tenure was marked by significant contributions to emerging brand partnerships, driving innovation in the beauty and personal care sectors. Estée Lauder has not provided specific reasons for her departure, noting only that she is stepping away to explore new opportunities.
L'Oréal Expands in India with Strategic Investments in Deconstruct and Arata
L’Oréal’s venture fund, BOLD (Business Opportunities for L’Oréal Development), has strategically invested in two emerging Indian beauty brands, Deconstruct and Arata, during their Series A funding rounds. This move underscores L’Oréal’s commitment to expanding beyond its core markets and tapping into India’s rapidly growing beauty and personal care sector. By supporting these brands, L’Oréal aims to strengthen its presence in a market with increasing consumer interest in beauty products. These investments reflect L’Oréal’s belief that India will become a key player in the global beauty industry, signaling the company's long-term strategic focus on this region.
Bath & Body Works Adjusts Growth Projections Amid Economic Challenges
Bath & Body Works has issued a cautious fiscal 2025 outlook, projecting net sales growth of 1-3%, below analysts' expectations of 2.8%. The company attributes this to new US tariffs on Chinese imports and reduced consumer demand for fragrances and scented candles. Full-year earnings per share are forecasted between $3.25 and $3.60, slightly missing the consensus of $3.62. Despite this, the retailer exceeded holiday-quarter estimates with adjusted earnings of $2.09 per share and sales of $2.79 billion. Bath & Body Works also announced a $500 million share repurchase program. Rising operational costs from tariffs and economic volatility are pressuring the company's core business, while consumers shift towards private-label products due to inflation and higher interest rates.